What is Mesalamine (rectal)?

Category: Prescription Drugs

Most popular types: Canasa Rowasa Salofalk Enema

false

Mesalamine, a derivative of 5-aminosalicylic acid, is an anti-inflammatory agent. It can be used to treat ulcerative colitis and Crohn’s disease. It may be applied rectally to help treat inflammation involving the end of the colon (sigmoid colon) or the rectum.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Ulcerative colitis 303 15
Crohn's disease 177 5
Proctitis 4 2
Bleeding (hemorrhage) 1 0
Mucus in stool 1 1

Show all 7 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 1
Mild 5
None 16

Commonly reported side effects and conditions associated with Mesalamine (rectal)

Side effect Patients Percentage
Abdominal cramps 2
Bowel urgency 1
Diarrhea 1
Flatulence 1
Loose bowel movements 1

Why patients stopped taking Mesalamine (rectal)

Multiple reasons could be selected

Reason Patients Percentage
Other 8
Course of treatment ended 6
Did not seem to work 5
Doctor's advice 3
Personal research 2
Change in health plan coverage 1
Expense 1
See all 19 patients who've stopped taking Mesalamine (rectal)

Duration

Stopped taking Mesalamine (rectal)

Duration Patients Percentage
Less than 1 month 7
1 - 6 months 3
6 months - 1 year 1
1 - 2 years 5
2 - 5 years 2
5 - 10 years 2
Adherence
Adherence Evaluations Percentage
Always 15
Usually 6
Sometimes 1
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 2
Somewhat hard to take 9
A little hard to take 8
Not at all hard to take 3
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 1
$50-99 0
$25-49 4
< $25 6
Not specified 11

What people switch to and from

Patients started taking Mesalamine (rectal) after stopping:

Treatment Patients Percentage
Mesalamine (Pentasa) 4

Patients stopped taking Mesalamine (rectal) and switched to:

Treatment Patients Percentage
Adalimumab (Humira) 1
Azathioprine (Imuran) 1
Balsalazide (Colazal) 1
Infliximab (Remicade) 1
Mercaptopurine (Purinethol) 1

Show all 7 treatments patients report switching to

Last updated:

1 patient evaluation for Mesalamine (rectal)

Jul 7, 2012 (Started Nov 01, 2010)

  • Effectiveness
    Moderate (for ulcerative colitis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: As needed
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Mesalamine (rectal)